Javier San Martin

Director Técnico/Científico/I+D en ATHIRA PHARMA, INC. .

Fortuna: 4 M $ al 30/04/2024

58 años

Health Technology

Consumer Services

Cargos activos de Javier San Martin

Empresas	Cargo	Inicio	Fin
ATHIRA PHARMA, INC.	Director Técnico/Científico/I+D	15/04/2024	-

Empresas	Cargo	Inicio	Fin
ARROWHEAD PHARMACEUTICALS, INC.	Director Técnico/Científico/I+D	18/11/2019	01/02/2024
ULTRAGENYX PHARMACEUTICAL INC.	Corporate Officer/Principal	01/12/2013	01/11/2019
AMGEN INC.	Corporate Officer/Principal	-	-
ELI LILLY AND COMPANY	Corporate Officer/Principal	-	-
ALDER BIOPHARMACEUTICALS, INC.	Corporate Officer/Principal	-	-

University of Buenos Aires School of Medicine

Doctorate Degree

Internacional

Estados Unidos	7
Argentina	2

Operativa

Corporate Officer/Principal	4
Chief Tech/Sci/R&D Officer	2
Doctorate Degree	1

Sectorial

Health Technology	7
Consumer Services	2

Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Empresas cotizadas	5
AMGEN INC.	Health Technology
ELI LILLY AND COMPANY	Health Technology
ARROWHEAD PHARMACEUTICALS, INC.	Health Technology
ULTRAGENYX PHARMACEUTICAL INC.	Health Technology
ATHIRA PHARMA, INC.	Health Technology

Empresas privadas	1
Lundbeck Seattle BioPharmaceuticals, Inc. Lundbeck Seattle BioPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lundbeck Seattle BioPharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which focuses on transforming the migraine treatment paradigm through the discovery, development and commercialization of novel therapeutic antibodies. Its product includes Eptinezumab, is an investigational monoclonal antibody (mAb) that inhibits calcitonin gene-related peptide (CGRP) and is currently in late-stage clinical development for the prevention of migraine. The company was founded by Randall C. Schatzman, Mark J. Litton, and John A. Latham in January 2004 and is headquartered in Bothell, WA.	Health Technology

Empresas privadas

Health Technology